Published in Virchows Arch on December 01, 1999
SOX2 contributes to melanoma cell invasion. Lab Invest (2011) 1.21
Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression. Exp Mol Med (2012) 0.98
BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity. Br J Cancer (2014) 0.87
Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase. Br J Cancer (2010) 0.82
The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells. Matrix Biol (2015) 0.79
Investigation of the role of MMP3 -1171insA polymorphism in cutaneous malignant melanoma - a preliminary study. Biotechnol Biotechnol Equip (2014) 0.78
Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness? Diagn Pathol (2008) 0.75
Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci U S A (1997) 4.82
Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum (2001) 3.08
Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum (1977) 2.14
Mast cells at sites of cartilage erosion in the rheumatoid joint. Ann Rheum Dis (1984) 1.94
Calcification in atherosclerotic plaque of human carotid arteries: associations with mast cells and macrophages. J Pathol (1998) 1.86
Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion. Arthritis Rheum (1984) 1.85
Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum (1984) 1.85
Small molecular weight beta 1 serum protein which specifically inhibits human collagenases. Nature (1976) 1.79
Localization of the binding site for cell attachment in the alpha1(I) chain of collagen. J Biol Chem (1978) 1.79
Collagenase production by rheumatoid synovial cells: morphological and immunohistochemical studies of the dendritic cell. Ann Rheum Dis (1979) 1.50
Collagenase immunolocalization in cultures of rheumatoid synovial cells. Science (1978) 1.49
Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J Pathol (1997) 1.40
Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann Rheum Dis (1995) 1.37
Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem (1994) 1.37
Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis (1995) 1.35
Purification, characterization and inhibition of human skin collagenase. Biochem J (1978) 1.35
Purification of rheumatoid synovial collagenase and its action on soluble and insoluble collagen. Eur J Biochem (1975) 1.30
Inhibition of human collagenase activity by a small molecular weight serum protein. Biochem Biophys Res Commun (1975) 1.29
Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma. Br J Cancer (1986) 1.15
Neovascularization in early atherosclerotic lesions of human carotid arteries: its potential contribution to plaque development. Hum Pathol (1999) 1.12
Collagenolytic mechanisms in tumor cell invasion. Cancer Metastasis Rev (1984) 1.12
Histamine stimulates prostaglandin E production by rheumatoid synovial cells and human articular chondrocytes in culture. Arthritis Rheum (1986) 1.11
Action of rheumatoid synovial collagenase on cartilage collagen. Different susceptibilities of cartilage and tendon collagen to collagenase attack. Eur J Biochem (1975) 1.08
Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol (1999) 1.06
An actin-like protein from amoebae of dictyostelium discoideum. Arch Biochem Biophys (1972) 1.05
Expression of vitamin D receptors and matrix metalloproteinases in osteoarthritic cartilage and human articular chondrocytes in vitro. Osteoarthritis Cartilage (2001) 1.05
The disulphide-bonded nature of procollagen and the role of the extension peptides in the assembly of the molecule. Biochem J (1977) 1.03
Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol Int (1993) 1.02
Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries. J Pathol (1999) 1.02
Comparative studies of adherent rheumatoid synovial cells in primary culture: characterisation of the dendritic (stellate) cell. Rheumatol Int (1987) 1.01
Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab (1994) 1.00
Acetylcholinesterase activity in the brain of rat pups and dams after exposure to lead via the maternal water supply. Neurotoxicology (1984) 1.00
The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion. Arthritis Res (1999) 0.99
Histamine H2 receptors on chondrocytes derived from human, canine and bovine articular cartilage. Biochem J (1985) 0.98
Collagenase and its natural inhibitors in relation to the rheumatoid joint. Connect Tissue Res (1977) 0.98
Collagenase immunolocalization studies of cutaneous secondary melanomas. Br J Cancer (1980) 0.98
Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. Br J Rheumatol (1998) 0.98
Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II. Biochem J (1995) 0.97
Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. J Reprod Fertil (1996) 0.97
Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NF. Br J Cancer (1991) 0.97
Host-mediated effectors of tumor invasion: role of mast cells in matrix degradation. Clin Exp Metastasis (1986) 0.96
Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma. Int J Colorectal Dis (1994) 0.96
Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages, and synoviocytes. Ann Rheum Dis (1999) 0.94
Histamine H1 receptors on adherent rheumatoid synovial cells in culture: demonstration by radioligand binding and inhibition of histamine-stimulated prostaglandin E production by histamine H1 antagonists. Ann Rheum Dis (1987) 0.93
Matrix metalloproteinases in normal menstruation. Hum Reprod (1996) 0.93
Comparative and combined effects of transforming growth factors alpha and beta, interleukin-1 and interferon-gamma on rheumatoid synovial cell proliferation, glycolysis and prostaglandin E production. Rheumatol Int (1989) 0.93
Catabolism of intact fibrillin microfibrils by neutrophil elastase, chymotrypsin and trypsin. FEBS Lett (1994) 0.93
A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast. Br J Cancer (1989) 0.92
Mast-cell products and heparin stimulate the production of mononuclear-cell factor by cultured human monocyte/macrophages. Biochem J (1985) 0.92
Characterization and serum inhibition of neutral collagenase from cultured dog gingival tissue. Biochim Biophys Acta (1978) 0.91
Histamine H2 receptors on foetal-bovine articular chondrocytes. Biochem J (1983) 0.91
Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod (1995) 0.89
Differences in the physical properties of collagenases isolated from rheumatoid synovium and human skin. Biochem Biophys Res Commun (1973) 0.89
Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol (2001) 0.89
Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro. Ann Rheum Dis (1998) 0.88
Bidirectional erosion of cartilage in the rheumatoid knee joint. Ann Rheum Dis (1985) 0.88
A neutral collagenase from human gastric mucosa. Biochem J (1976) 0.88
All three chains of 1 alpha 2 alpha 3 alpha collagen from hyaline cartilage resist human collagenase. Biochem Biophys Res Commun (1984) 0.87
Synthesis of classical pathway complement components by chondrocytes. Immunology (1996) 0.87
Morphometric effects of postnatal lead exposure on hippocampal development of the 15-day-old rat. Brain Res (1982) 0.85
Demonstration of histamine H2 receptors on human melanoma cells. Biochem Biophys Res Commun (1988) 0.85
Susceptibility of cartilage collagens type II, IX, X, and XI to human synovial collagenase and neutrophil elastase. Eur J Biochem (1988) 0.84
Comparative studies of collagenase and stromelysin-1 expression by rheumatoid synoviocytes in vitro. Virchows Arch (1995) 0.84
IgE antibodies specific for cartilage collagens type II, IX and XI in rheumatic diseases. Scand J Rheumatol (1993) 0.84
Degradation of cartilage collagens type II, IX, X and XI by enzymes derived from human articular chondrocytes. Matrix (1990) 0.84
Evidence for both histamine H1 and H2 receptors on human articular chondrocytes. Ann Rheum Dis (1987) 0.84
Effect of recombinant cytokines on glycolysis and fructose 2,6-bisphosphate in rheumatoid synovial cells in vitro. Biochem J (1988) 0.83
Extraction of an actomyosin-like pootein from amoebae of Dictyostelium discoideum. J Cell Physiol (1970) 0.83
Mast cell regulation of human endometrial matrix metalloproteinases: A mechanism underlying menstruation. Biol Reprod (1998) 0.83
Comparative effects of interleukin 1 and a phorbol ester on rheumatoid synovial cell fructose 2,6-bisphosphate content and prostaglandin E production. Biochem Biophys Res Commun (1988) 0.82
Identification and partial characterisation of the non-collagenous amino- and carboxyl-terminal extension peptides of cartilage procollagen. Biochem Biophys Res Commun (1976) 0.82
Serum IgE anti-cartilage collagen antibodies in rheumatoid patients. Rheumatol Int (1991) 0.81
Immunolocalization of collagenase in periodontal disease. J Periodontal Res (1981) 0.81
Distribution of DDT, DDD, and DDE in tissues of neonatal rats and in milk and other tissues of mother rats chronically exposed to DDT. Toxicol Appl Pharmacol (1971) 0.80
Production of matrix metalloproteinase 3 (stromelysin) by cultured ovine endometrial cells. J Cell Sci (1991) 0.80
Action of human skin collagenase on cartilage collagen. FEBS Lett (1973) 0.80
Histamine stimulates matrix metalloproteinase-3 and -13 production by human articular chondrocytes in vitro. Ann Rheum Dis (2002) 0.79
Histamine and PGE(2) stimulate the production of interleukins -6 and -8 by human articular chondrocytes in vitro. 6. Human and clinical aspects of histamine. Inflamm Res (2006) 0.79
Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC. Int J Cancer (1993) 0.79
Effect of cartilage proteoglycans on human collagenase activities. Biochim Biophys Acta (1977) 0.79
Gelatinase B (MMP-9) expression and survival in colorectal cancer patients. Int J Colorectal Dis (1997) 0.79
A perspective of lead poisoning in antiquity and the present. Neurotoxicology (1984) 0.78
Histamine stimulates the proliferation of human articular chondrocytes in vitro and is expressed by chondrocytes in osteoarthritic cartilage. Ann Rheum Dis (2003) 0.78
Morphometric effects of preweaning lead exposure on the hippocampal formation of adult rats. Neurotoxicology (1984) 0.78
Matrix metalloproteinases and their tissue inhibitors at the ovine trophoblast-uterine interface. J Reprod Fertil Suppl (1995) 0.78
Evidence against a significant role for mast cells in blastocyst implantation in the rat and mouse. Reprod Fertil Dev (1996) 0.78
Cleavage of collagen type X by human synovial collagenase and neutrophil elastase. Matrix (1989) 0.78
Production of matrix metalloproteinase 1 (interstitial collagenase) and matrix metalloproteinase 2 (gelatinase A: 72 kDa gelatinase) by ovine endometrial cells in vitro: different regulation and preferential expression by stromal fibroblasts. J Reprod Fertil (1993) 0.77
Effects of 1 alpha,25dihydroxyvitaminD3 on matrix metalloproteinase expression by rheumatoid synovial cells and articular chondrocytes in vitro. Ann N Y Acad Sci (1999) 0.77
Mast cells in cervical ripening--an immunohistochemical and biomechanical study in rats. Eur J Obstet Gynecol Reprod Biol (1997) 0.77
Demonstration of nuclear 3H-estradiol binding in hypothalamus and amygdala of female, androgenized-female, and male rats. Neuroendocrinology (1974) 0.77
Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis. J Clin Pathol (2003) 0.77
Eosinophils are an insignificant cellular component of rheumatoid synovium in patients with late stage disease: comparative distributions with mast cells and macrophages. Ann Rheum Dis (1996) 0.76
Phenotype of mast cells in the brain tumor. Capillary hemangioblastoma. Folia Neuropathol (1999) 0.76
Mechanisms of neurotoxic action of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) in immature and adult rats. J Pharmacol Exp Ther (1970) 0.76
Toxicokinetics of Ro 5-4864, lindane and picrotoxin compared. Pharmacol Biochem Behav (1991) 0.76
Plasminogen activator release from cultured murine mast cells. Biochem Biophys Res Commun (1988) 0.76
Ontogenesis of drug-induced tremor in the rat. J Pharmacol Exp Ther (1970) 0.76
Studies on the relative insensitivity of the immature rat to the neurotoxic effects of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT). J Pharmacol Exp Ther (1969) 0.75